Physiological and Appetitive Effects of CBD Supplementation
1 other identifier
interventional
30
1 country
1
Brief Summary
CBD may affect metabolic control and energy intake. However, there is currently little data regarding these specific outcomes in humans. Therefore, this study will investigate whether four weeks of supplementation with 60 mg/day CBD affects energy intake at a single meal, and or fasting blood-based markers of appetite regulation and metabolic health. Healthy, adult volunteers will be assigned to placebo or CBD supplementation, in a randomized controlled trial, comparing changes in outcomes across the supplementation period between groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2023
CompletedStudy Start
First participant enrolled
January 20, 2023
CompletedFirst Posted
Study publicly available on registry
March 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 5, 2024
CompletedMarch 17, 2023
March 1, 2023
8 months
January 16, 2023
March 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Energy Intake
Self-selected energy intake at an ad libitum mixed meal
Baseline and after 4 weeks supplementation
Secondary Outcomes (9)
CBD
Baseline and after 4 weeks supplementation
Liver transaminases
Baseline and after 4 weeks supplementation
Hormones implicated in appetite regulation
Baseline and after 4 weeks supplementation
Lipoproteins
Baseline and after 4 weeks supplementation
Glucose
Baseline and after 4 weeks supplementation
- +4 more secondary outcomes
Study Arms (2)
CBD
EXPERIMENTAL1 mL hemp oil containing 60 mg/mL CBD, daily.
Placebo
PLACEBO COMPARATOR1 mL hemp oil containing 0 mg/mL CBD, daily.
Interventions
Daily supplementation with 1 ml hemp oil containing 60 mg CBD, applied orally
Daily supplementation with 1 ml hemp oil containing 0 mg CBD, applied orally
Eligibility Criteria
You may not qualify if:
- No history of any substance abuse
- Have used tobacco regularly (\>2x in a week) within the past 6 months
- Are suffering from any condition that may affect study outcomes
- Currently use any prescription or over-the-counter medications (except for hormonal contraception and simple painkillers)
- Have given a standard blood donation within 30 days of screening
- Are currently pregnant or lactating
- Are allergic/intolerant to any ingredients in food items we provide during the study (relevant allergens: oats, milk)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loughborough University
Loughborough, Leicestershire, LE113TU, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Double-blind
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Lecturer in Nutrition
Study Record Dates
First Submitted
January 16, 2023
First Posted
March 17, 2023
Study Start
January 20, 2023
Primary Completion
October 1, 2023
Study Completion
January 5, 2024
Last Updated
March 17, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Permanently, after publication of study findings.
Individual data for study outcomes will be shared on the Loughborough University Research Repository